Showing results (551-560 of 929) with videos related to

Sort By:
Pageof 93
The Primary Care Companion for CNS Disorders|February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive DisorderClotilde Guidetti, Giulia Serra, Luca Pani, et al.
Contemporary Clinical Trials|April 21, 2016
Examining the efficacy of d-cycloserine to augment therapeutic learning in depressionMichael W Otto, Josephine Lee, Stefan G Hofmann, et al.
Psychiatry Research|December 14, 2004
Factors that differentiate early vs. later onset of major depression disorderSidney Zisook, A John Rush, Ari Albala, et al.
Depression and Anxiety|March 11, 2006
Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacksDarin D Dougherty, Ali A Bonab, William E Ottowitz, et al.
The American Journal on Addictions|December 24, 2010
Compulsive alcohol use and other high-risk behaviors among college studentsPaola Pedrelli, Stella Bitran, Irene Shyu, et al.
The International Journal of Neuropsychopharmacology|September 14, 2004
Obesity among outpatients with major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy J Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|November 2, 2005
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Gustavo Kinrys, et al.
The Journal of Clinical Psychiatry|October 6, 2007
Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study dataDavid W Morris, A John Rush, Shailesh Jain, et al.
Archives of General Psychiatry|August 6, 2008
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment featuresA John Rush, Stephen R Wisniewski, Diane Warden, et al.
Pageof 93